Welcome to
Regional Institute of Ophthalmology Kolkata

Ongoing Research Activities

Retina Research Unit
 

 

Drug Trial

IQVIA-    

A Global, Phase III, Double Blind, Randomized Controlled Study to Compare the Efficacy, Safety & Immunogenicity of LUBT010 with Lucentis® in Patients with Neovascular Age-Related Macular Degeneration

PI-   Dr Asim Kumar Ghosh

COI- Dr Sneha Jain, Dr. Soumyadeep Majumdar, Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Shyamapada Biswas

PPD-

A phase III Randomized, Double-Masked, Parallel Group, Multicenter Study to Compare the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity between SCD411 and Eylea in Subjects with Neovascular Age-related Macular Degeneration

 PI-   Dr Asim Kumar Ghosh

COI- Dr Sneha Jain, Dr. Soumyadeep Majumdar, Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Shyamapada Biswas

SUN-

A phase III, Comparative, Double Blind, Randomized,  Multi-centric Study to compare the Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab with Reference Biologic  in Patient with Neovascular Age-related Macular Degeneration (wet AMD).

 

PI-   Dr Asim Kumar Ghosh

COI-  Dr. Tania Ray Bhadra

 

QILU-

 A Randomized, Phase 3, Double-masked, Parallel- group, Multicenter Study to Compare Efficacy and Safety of QLI205 Versus Lucentis in Subjects With Neovascular Age-related Macular Degeneration.

PI- Dr. Krishnapada Baidya

COI- Dr. Lakshmi Kanta Mondal, Dr. Devadri  Basu , Dr. Paridhi Todi, Dr. Sneha Jain, Dr. Amrita Pal, Dr. Arindam Roy

LAMBDA-  "A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of IntasRanibizumab with Lucentis@ in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)"

PI- Dr. Lakshmi Kanta Mondal

COI- Dr Sneha Jain,  Dr. Tania Ray Bhadra, Dr. Paridhi Todi, Dr. Abhishek  Chaudhuri

 

Research Activities related to Eye Bank